Aptus Pharma IPO
Aptus Pharma IPO is an SME IPO raising ₹13 Cr at ₹65 – ₹70 a share. It listed on 30 Sept 2025 at ₹81, +15.4% against its issue price of ₹70, and trades at ₹472 today (+1586.1% since issue, after adjusting for bonus issues or splits: one share allotted at the IPO is now 2.5 shares). It was subscribed 22× in total.
22.2 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Source documents
What the issuer and the exchanges published. Everything else on this tab is read out of these.
Read-out of the prospectus
A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.